Grace Therapeutics, Inc. (GRCE)

Investing Cash Flow

$0.00

TTM · Period ending: · USD

GRCE logo

GRCE Investing Cash Flow

Latest reported$0.00
GRCE Cash from Investing (-$2.34M → $0.00)
High-resolution chart · PNG

GRCE investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Grace Therapeutics, Inc. Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
0
0
104,000
13,153,000
-3,522,000
-12,384,079
11,503,673
-9,442,000
-318,256
6,851,634
6,072,569
6,095,894
-17,477,286
1,854,661
-3,009,237
-2,573,694
1,904,761
-2,344,465
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.